feed,title,long_url,short_url
Benzinga,"Global Blood Therapeutics' Sickle Cell Med Results In Rapid, Durable Improvements In Hemoglobin Levels Throughout 72 Weeks Of Treatment",https://benzinga.com/general/biotech/21/04/20534736/global-blood-therapeutics-sickle-cell-med-results-in-rapid-durable-improvements-in-hemoglobin-lev,https://j.mp/3dQA9GW
